Press releasePRNewswire
Sera Prognostics
SERA · NASDAQ
$2.03+$0.00 (+0.00%)TodayMarket closed ·
Prev close $2.03
Latest news
- Press releasePRNewswire
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
- Press releasePRNewswire
SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
- Press releasePRNewswire
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026
- Press releasePRNewswire
PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE
- Press releasePRNewswire
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
- Press releasePRNewswire
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH
- Press releasePRNewswire
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
- Press releasePRNewswire
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
- News
Earnings Scheduled For May 6, 2026
- Press releasePRNewswire
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026
- Press releasePRNewswire
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
- News
Earnings Scheduled For March 18, 2026
- Press releasePRNewswire
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026
- Press releasePRNewswire
SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE
- Press releasePRNewswire
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications
- Press releasePRNewswire
Sera Announces Publication Acceptance for PRIME Study
- Press releaseBusiness Wire
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
- Press releasePRNewswire
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
- News
Earnings Scheduled For November 13, 2025
- Press releasePRNewswire
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025
- Press releasePRNewswire
Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer
- Press releasePRNewswire
SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE
- Press releasePRNewswire
SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
- Press releasePRNewswire
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025
- Press releasePRNewswire
SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
- Press releasePRNewswire
SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE
- Press releasePRNewswire
SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsChris Katje
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.